NCT03551860

Brief Summary

Investigators hypothesise that for patients undergoing elective total hip replacements, a single injection Transmuscular Quadratus Lumborum (TQL) block, when compared to a single injection Fascia Iliaca Block (FIB), will provide better analgesia and less motor block in the initial 24 hour period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2018

Completed
18 days until next milestone

Study Start

First participant enrolled

April 10, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 11, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

June 11, 2018

Status Verified

May 1, 2018

Enrollment Period

6 months

First QC Date

March 23, 2018

Last Update Submit

June 8, 2018

Conditions

Keywords

Total hip replacementMotor block post-operativelyMorphine consumption post-operativelyTransmuscular Quadratus Nerve BlockFascia Iliaca Nerve Block

Outcome Measures

Primary Outcomes (1)

  • 24 hour morphine consumption between the two groups

    Intravenous Patient Controlled Analgesia (PCA) Morphine will be set up and explained to all participants. The AMNCH hospital standard will be use. This is 2mg/ml concentration; 1mg dose; 6 minute lockout period between administration; maximum morphine consumption of 40mg within a 4 hour period.

    24 hour post-operative period

Secondary Outcomes (2)

  • Motor Block

    24 hours post-operative period - measured at 6 and 24 hours

  • Numerical Rating Scale (NRS) for Pain

    24 hours post-operative period - measured at 6 and 24 hours

Study Arms (2)

TQL Group

EXPERIMENTAL

Administration of a single shot transmuscular quadratus lumborum (TQL) peripheral nerve block following spinal neuraxial blockade.

Procedure: TQL

FIB Group

ACTIVE COMPARATOR

Administration of a single shot fascia iliac (FIB) peripheral nerve block following spinal neuraxial blockade.

Procedure: FIB

Interventions

TQLPROCEDURE

For the intervention of TQL peripheral nerve block the needle tip will be advanced by in-plane technique and local anaesthetic will be deposited between psoas major and quadratus lumborum muscles. 20 ml of 0.25% bupivacaine will be administered under ultrasound guidance following careful intermittent aspiration. The needle tip will not be repositioned unless the patient complains of paraesthesia. For the intervention of spinal neuraxial blockade the needle will be advanced into the subarachnoid space. Once clear CSF is visualised 3.2ml 0.5% plain bupivacaine will be infiltrated.

Also known as: Transmuscular Quadratus Nerve Block
TQL Group
FIBPROCEDURE

The needle tip will be advanced by in-plane technique and local anaesthetic will be deposited deep to the fascia iliaca. 20ml of 0.25% bupivacaine will be administered under ultrasound guidance following careful intermittent aspiration. The needle tip will not be repositioned unless the patient complains of paraesthesia. For the intervention of spinal neuraxial blockade the needle will be advanced into the subarachnoid space. Once clear CSF is visualised 3.2ml 0.5% plain bupivacaine will be infiltrated.

Also known as: Fascia Iliaca Nerve Block
FIB Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing elective total hip replacements under spinal anaesthesia
  • ASA 1-3
  • Age \> 18 yrs.
  • Patient is able to provide written informed consent

You may not qualify if:

  • Local infection
  • Allergy to local anaesthetics
  • Severe coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adelaide and Meath Hospital, Incorporating National Children Hospital

Tallaght, Dublin 24, Ireland

RECRUITING

Related Publications (4)

  • Petis SM, Howard JL, Lanting BA, Marsh JD, Vasarhelyi EM. In-Hospital Cost Analysis of Total Hip Arthroplasty: Does Surgical Approach Matter? J Arthroplasty. 2016 Jan;31(1):53-8. doi: 10.1016/j.arth.2015.08.034. Epub 2015 Aug 29.

    PMID: 26387922BACKGROUND
  • Gaffney CJ, Pelt CE, Gililland JM, Peters CL. Perioperative Pain Management in Hip and Knee Arthroplasty. Orthop Clin North Am. 2017 Oct;48(4):407-419. doi: 10.1016/j.ocl.2017.05.001. Epub 2017 Jun 29.

    PMID: 28870302BACKGROUND
  • Ueshima H, Yoshiyama S, Otake H. RETRACTED: The ultrasound-guided continuous transmuscular quadratus lumborum block is an effective analgesia for total hip arthroplasty. J Clin Anesth. 2016 Jun;31:35. doi: 10.1016/j.jclinane.2015.12.033. Epub 2016 Mar 22.

    PMID: 27185672BACKGROUND
  • La Colla L, Uskova A, Ben-David B. Single-shot Quadratus Lumborum Block for Postoperative Analgesia After Minimally Invasive Hip Arthroplasty: A New Alternative to Continuous Lumbar Plexus Block? Reg Anesth Pain Med. 2017 Jan/Feb;42(1):125-126. doi: 10.1097/AAP.0000000000000523. No abstract available.

    PMID: 27997495BACKGROUND

Study Officials

  • Karthikeyan K Srinivasan, MD.,FCARCSI

    Adelaide and Meath Hospital, Incorporating National Children's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karthikeyan K Srinivasan, MD.,FCARCSI

CONTACT

Barbara Cusack, MCAI

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Due to nature of intervention (one single injection vs a second single injection in different anatomical location) the participant and the care provider cannot be blinded.The investigator will use an already filled data collection sheet and enter randomised data into a master file. The data will be analysed by an individual blinded to the which group the participant was in.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Anaesthetist

Study Record Dates

First Submitted

March 23, 2018

First Posted

June 11, 2018

Study Start

April 10, 2018

Primary Completion

October 1, 2018

Study Completion

December 1, 2018

Last Updated

June 11, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations